Your trusted source for insights on medical cosmetology, addiction treatment, and health products.

Beauty TipsEye Make upFashionFood & DrinksHealthNews

VA Secretary Tells Trump About Psychedelics’ Potential To Combat Military Veteran Suicide Crisis At Cabinet Meeting



From toxifillers.com with love

{“uid”:”4″,”hostPeerName”:”https://www.marijuanamoment.net”,”initialGeometry”:”{\”windowCoords_t\”:10,\”windowCoords_r\”:1546,\”windowCoords_b\”:848,\”windowCoords_l\”:10,\”frameCoords_t\”:4232.359375,\”frameCoords_r\”:988,\”frameCoords_b\”:4552.359375,\”frameCoords_l\”:248,\”styleZIndex\”:\”auto\”,\”allowedExpansion_t\”:0,\”allowedExpansion_r\”:0,\”allowedExpansion_b\”:0,\”allowedExpansion_l\”:0,\”xInView\”:0,\”yInView\”:0}”,”permissions”:”{\”expandByOverlay\”:true,\”expandByPush\”:true,\”readCookie\”:false,\”writeCookie\”:false}”,”metadata”:”{\”shared\”:{\”sf_ver\”:\”1-0-43\”,\”ck_on\”:1,\”flash_ver\”:\”0\”}}”,”reportCreativeGeometry”:false,”isDifferentSourceWindow”:false,”goog_safeframe_hlt”:{}}” scrolling=”no” marginwidth=”0″ marginheight=”0″ width=”480″ height=”320″ data-is-safeframe=”true” sandbox=”allow-forms allow-popups allow-popups-to-escape-sandbox allow-same-origin allow-scripts allow-top-navigation-by-user-activation” allow=”private-state-token-redemption;attribution-reporting” aria-label=”Advertisement” tabindex=”0″ data-google-container-id=”4″ style=”border: 0px; vertical-align: bottom;”>

Earlier this week, Collins separately reiterated his commitment to exploring psychedelic therapy options for the veteran community in response to a X post from Matthew Buckley, chairman of the No Fallen Heroes Foundation.

“I cannot remember a single president publicly talking about veteran suicide or, for that matter, asking about it directly to the VA secretary in a cabinet meeting in front of the whole country,” Buckley told Marijuana Moment. “So to hear [Collins] respond and say nonprofits like No Fallen Heroes Foundation are currently doing this work to help heal our heroes was an incredible moment for me.”

“I appreciate the words, but we need follow on action,” he added. “The VA and our government should live up to the promises made to the young men and women who answer the call to serve this great nation.”

Collins, for this part, disclosed earlier this month that he had an “eye-opening” talk with Kennedy about the therapeutic potential of psychedelic medicine. And he intends to press Congress to take action on the issue.

He also said that he’s open to the idea of having the government provide vouchers to cover the costs of psychedelic therapy for veterans who receive services outside of VA as Congress considers pathways for access.

In December, VA separately announced that it’s providing $1.5 million in funding to study the efficacy of MDMA-assisted therapy for veterans with PTSD and alcohol use disorder (AUD).

Last year, Rachel Yehuda, who has overseen some psychedelic research as director of mental health at VA’s James J. Peters Veterans Affairs Medical Center, also touted an initial study the agency funded that produced “stunning and robust results” from its first-ever clinical trial into MDMA therapy.

In January, former VA Under Secretary for Health Shereef Elnahal said that it was “very encouraging” that Trump’s pick to have Kennedy lead HHS has supported psychedelics reform. And he hoped to work with him on the issue if he stayed on for the next administration, but that didn’t pan out.

Meanwhile, advocates are also eager to see how Collins navigates marijuana policy issues at VA, which has historically resisted congressional efforts to reform rules around studying cannabis or authorizing government doctors to issue medical marijuana recommendations to veterans in legal states.

The official has a prior record of voting against medical cannabis access for military veterans during his time in Congress.

Separately, a GOP congressman recently cheered news that the Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members.

Another Republican congressman has also expressed optimism about the prospects of advancing psychedelics reform under Trump, arguing that the administration’s efforts to cut spending and the federal workforce will give agencies “spines” to tackle such complex issues.

Trump’s Pick To Lead DEA Says Marijuana Rescheduling Review Will Be ‘One Of My First Priorities’ In The Job

Image courtesy of Kristie Gianopulos.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Become a patron at Patreon!




Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. He’s covered drug policy for more than a decade—specializing in state and federal marijuana and psychedelics issues at publications that also include High Times, VICE and attn. In 2022, Jaeger was named Benzinga’s Cannabis Policy Reporter of the Year.




















Marijuana News In Your Inbox

 

Do not sell or share my personal information.

You have chosen to opt-out of the sale or sharing of your information from this site and any of its affiliates. To opt back in please click the “Customize my ad experience” link.

This site collects information through the use of cookies and other tracking tools. Cookies and these tools do not contain any information that personally identifies a user, but personal information that would be stored about you may be linked to the information stored in and obtained from them. This information would be used and shared for Analytics, Ad Serving, Interest Based Advertising, among other purposes.

For more information please visit this site’s Privacy Policy.





Source link